مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome.

Authors : Askeland A; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/complications ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/blood ; Obesity*/Obesity*/Obesity*/complications

Source: Scientific reports [Sci Rep] 2025 Mar 27; Vol. 15 (1), pp. 10652. Date of Electronic Publication: 2025 Mar 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017-2020.

Authors : Zheng C; Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.; Qi Z

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/epidemiology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/etiology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/etiology

Source: BMC gastroenterology [BMC Gastroenterol] 2025 Mar 12; Vol. 25 (1), pp. 163. Date of Electronic Publication: 2025 Mar 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.

Authors : Xue B; Shanxi Medical University, Taiyuan, Shanxi Province, China.; Wang Z

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/complications ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/complications ; Liver Cirrhosis*

Source: Journal of infection in developing countries [J Infect Dev Ctries] 2025 Feb 28; Vol. 19 (2), pp. 315-324. Date of Electronic Publication: 2025 Feb 28.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis.

Authors : Wei J; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.; Hui W

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/complications ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

Source: BMC infectious diseases [BMC Infect Dis] 2025 Feb 19; Vol. 25 (1), pp. 239. Date of Electronic Publication: 2025 Feb 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease.

Authors : Cho EH; Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Kim JA

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/blood ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/complications ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology

Source: PloS one [PLoS One] 2025 Feb 18; Vol. 20 (2), pp. e0318847. Date of Electronic Publication: 2025 Feb 18 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan: A cross-sectional study.

Authors : Komatsu K; Department of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan.; Sano K

Subjects: Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/blood ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/diagnosis ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/epidemiology

Source: PloS one [PLoS One] 2024 Dec 17; Vol. 19 (12), pp. e0315752. Date of Electronic Publication: 2024 Dec 17 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease.

Authors : Kim HJ; R&BD Center, hy Co., Ltd., 22, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si 17086, Republic of Korea.; Jeon HJ

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/metabolism ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy

Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 12; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD).

Authors : Barchetta I; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.; Zampieri M

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/genetics ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/metabolism ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jan 31; Vol. 26 (3). Date of Electronic Publication: 2025 Jan 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt.

Authors : Abd El Hamid AA; Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Mohamed AE

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/therapy ; Probiotics*/Probiotics*/Probiotics*/therapeutic use ; Tertiary Care Centers*

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Oct 08; Vol. 24 (1), pp. 354. Date of Electronic Publication: 2024 Oct 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study.

Authors : Liu H; Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Deng M

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/complications ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/physiopathology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/epidemiology

Source: Iranian journal of medical sciences [Iran J Med Sci] 2025 Jan 01; Vol. 50 (1), pp. 11-21. Date of Electronic Publication: 2025 Jan 01 (Print Publication: 2025).Publisher: Shiraz University of Medical Sciences Country of Publication: Iran NLM ID: 8104374 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome.

The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017-2020.

Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.

The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis.

Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease.

Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan: A cross-sectional study.

Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease.

Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD).

The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt.

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study.

اتصل بنا

اتبع